Financial Results & Limited Review for June 30, 2012
Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2012.14-08-2012
14-08-2012
Auditors Report for March 31, 2012.
Marksans Pharma Ltd has submitted to BSE a Copy of the Auditors Report for the period ended March 31, 2012.29-05-2012
Financial Results for March 31, 2012
Marksans Pharma Ltd has informed BSE about the Financial Results for the period ended March 31, 2012.29-05-2012
Publish Audited Results
Marksans Pharma Ltd has informed BSE that the Company will publish Annual Audited Results for the entire financial year ended March 31, 2012 before May 30, 2012. Therefore, unaudited financial results for the quarter ended March 31, 2012 will not be published or given to Stock Exchanges.28-04-2012
Financial Results & Limited Review for Dec 31, 2011
Marksans Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2011.13-02-2012
Financial Results for Sep 30, 2011
Marksans Pharma Ltd has informed BSE about the Financial Results for the period ended September 30, 2011.14-11-2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Mark Saldanha has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE:04-11-2011
Preferential allotment of Warrants
Marksans Pharma Ltd has informed BSE that pursuant to the Special Resolution passed by the shareholders of the Company at the 19th Annual General Meeting held on September 29, 2011 and in-principle approval received from the Stock Exchange, the Board of Directors of the Company has, at its meeting held on October 25, 2011, issued and allotted 1,75,00,000 Warrants (convertible into equal number of equity shares of Re. 1/- each) to Mr. Mark Saldanha...25-10-2011
Updates on Outcome of AGM
Marksans Pharma Ltd has informed BSE that the members at the 19th Annual General Meeting (AGM) of the Company held on September 29, 2011, inter alia, have transacted the following:1. Adoption of the Audited Balance Sheet as at March 31, 2011, the Profit and Loss Account for the period ended March 31, 2011 and the Reports of the Directors and the Auditors thereon....10-10-2011